Haloxazolam
From Wikipedia, the free encyclopedia
![]() |
|
Haloxazolam
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C17H14BrFN2O2 |
Mol. mass | 377.208 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | Hepatic |
Half life | ? |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
Schedule IV(US) |
Routes | Oral |
Haloxazolam (marketed under brand name Somelin) is a drug which is a benzodiazepine derivative.
Haloxazolam is not approved for sale in the United States or Canada.
Adinazolam, Alprazolam, Bentazepam, Bromazepam, Brotizolam, Camazepam, Chlordiazepoxide, Cinolazepam, Clobazam, Clonazepam, Clorazepate, Clotiazepam, Cloxazolam, Cyprazepam, Diazepam, Doxefazepam, Estazolam, Ethyl loflazepate, Etizolam, Fludiazepam, Flunitrazepam, Flurazepam, Flutazolam, Flutoprazepam, Gidazepam, Halazepam, Haloxazolam, Ketazolam, Loprazolam, Lorazepam, Lormetazepam, Medazepam, Mexazolam, Midazolam, Nimetazepam, Nitrazepam, Nordazepam, Oxazepam, Oxazolam, Phenazepam, Pinazepam, Prazepam, Quazepam, Temazepam, Tetrazepam, Tofisopam, Triazolam, Zolazepam